The third round of the RheumMadness tournament is complete! To see how your bracket is doing, head over to the RheumMadness Tourneytopia website.
Results for reach matchup in the IgG Four are reviewed below, including how the 7-member Blue Ribbon Panel (BRP) voted compared to participant picks. Huge thanks to our amazing panel for their thoughtful consideration.
Overall, the IgG Four turned out as participants expected. The BRP voted for CAR-T cells (6) over Dog osteoarthritis (1) in a landslide. Likewise, 36% of participants picked CAR-T cells to win this round, compared to 5% who thought Dog osteoarthritis would make it to the championship.
The other matchup was similarly lopsided. The BRP voted for Repro health guide (5) over PET in LVV (2). Likewise, 31% of participants picked Repro health guide to win this round, compared to 8% who picked PET in LVV.
Despite all the upsets in the prior three rounds, this is the final matchup that most participants were expecting to see according to Tourneytopia statistics.
So who will win it all? It seems that the majority of participants think CAR-T cells will take the top spot, but will the Blue Ribbon Panel agree? And whose bracket will come out on top?
What’s up next?
Results for the Interleukin Two (finale) will be released on Monday, April 4 at 8pm ET.
Following these results, we will announce the winning participants (ie – top score) in teach of the following 3 categories: (1) Attending / APP, (2) Fellow, and (3) Resident / Medical Student.
The prize is a RheumMadness coffee mug and a lifetime of bragging rights!
While you wait, you can enjoy the following RheumMadness content:
- New RheumMadness podcast episode where we recap the first two rounds of the tournament with Iman Qaiser (Blue Ribbon Panel member) and other members of the RheumMadness leadership team.
- Join the conversation on Twitter by tweeting #RheumMadness
We will also release one more RheumMadness podcast episode next week. Stay tuned, the learning isn’t over yet!
